Literature DB >> 25873719

Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality?

Borislav Dinov1, Arash Arya2, Alexandra Schratter2, Valentina Schirripa2, Lukas Fiedler2, Philipp Sommer2, Andreas Bollmann2, Sascha Rolf2, Christopher Piorkowski2, Gerhard Hindricks2.   

Abstract

BACKGROUND: Data on outcomes after catheter ablation of ventricular tachycardia (VT) in patients with nonischemic dilated cardiomyopathy (NIDCM) are insufficient. We aimed to investigate the effects of successful catheter ablation of VT on cardiac mortality in patients with NIDCM. METHODS AND
RESULTS: One hundred two patients with NIDCM (86 men; mean age, 58.8±15.2 years; mean ejection fraction, 33.3±11.9%) underwent VT ablation. After catheter ablation, a programmed ventricular stimulation to test for success was performed. Complete VT noninducibility was achieved in 62 (61%) patients and partial success or failure in 32 (31%) patients. During 2 years of follow-up, VT recurrence was observed in 33 patients (53%) without inducible VTs and in 24 patients (75%) with inducible VT inducible (P=0.041). VT inducibility was associated with higher VT recurrence (adjusted hazard ratio, 1.84; 95% confidence interval, 1.08-3.13; P=0.025). The primary end point of all-cause mortality was reached in 9 patients (15%) with noninducible VTs versus 11 patients (34%) with inducible sustained VTs (P=0.026). VT inducibility was associated with all-cause mortality (adjusted hazard ratio, 2.73; 95% confidence interval, 1.003-7.43; P=0.049).
CONCLUSIONS: In patients with NIDCM and recurrent sustained VTs, a complete ablation of all inducible VTs may be achieved in 60% of the cases. The complete noninducibility may be a preferable end point of ablation because it was associated with better long-term success. Importantly, if possible to achieve through ablation, a complete VT noninducibility was associated with reduction of the likelihood for all-cause mortality in patients with NIDCM.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathy, dilated; catheter ablation; mortality; tachycardia, ventricular

Mesh:

Year:  2015        PMID: 25873719     DOI: 10.1161/CIRCEP.114.002295

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  12 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.

Authors:  Qi Jin; Peter Karl Jacobsen; Steen Pehrson; Xu Chen
Journal:  Clin Cardiol       Date:  2017-08-17       Impact factor: 2.882

3.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

4.  Ablation of Refractory Ventricular Tachycardia Using Intramyocardial Needle Delivered Heated Saline-Enhanced Radiofrequency Energy: A First-in-Man Feasibility Trial.

Authors:  Douglas L Packer; David J Wilber; Suraj Kapa; Katia Dyrda; Isabelle Nault; Ammar M Killu; Arvindh Kanagasundram; Travis Richardson; William Stevenson; Atul Verma; Michael Curley
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-07-01

Review 5.  Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.

Authors:  Jorge Romero; Rahul Chaudhary; Jalaj Garg; Florentino Lupercio; Neeraj Shah; Rahul Gupta; Talha Nazir; Babak Bozorgnia; Andrea Natale; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2017-07-03       Impact factor: 1.900

Review 6.  Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?

Authors:  Gerasimos Dimitropoulos; Georgios Leventogiannis; Joseph De Bono
Journal:  Curr Heart Fail Rep       Date:  2018-08

7.  The year in cardiology 2015: arrhythmias and device therapy.

Authors:  Jan Steffel; Pierre Jais; Gerhard Hindricks
Journal:  Eur Heart J       Date:  2016-01-03       Impact factor: 29.983

8.  Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm.

Authors:  Bashar Aldhoon; Dan Wichterle; Petr Peichl; Robert Čihák; Josef Kautzner
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

9.  Paradox of Appropriate Implantable Cardioverter-Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk.

Authors:  Ryan G Aleong; William H Sauer
Journal:  J Am Heart Assoc       Date:  2017-08-19       Impact factor: 5.501

10.  Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.

Authors:  Kenji Okubo; Lorenzo Gigli; Paolo Della Bella
Journal:  J Arrhythm       Date:  2018-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.